It also adds weight to the argument that an IDH1 mutation can be an initiating event in gliomagenesis, explaining the high frequency of clonal IDH1 mutations in human gliomas and their presence in both primary and recurrent gliomas [43]. The gene discussed is IDH1; the disease is central nervous system cancer.